Jones Lang LaSalle
Covance in $8.9M Signet Acquisition
Martin C. Daks
NJBIZ Staff
6/1/2006
Covance has announced that is has acquired substantially all of the assets belonging to Signet Laboratories for $8.9 million. Princeton-based Covance is a drug development services firm. It works with pharmaceutical and biotech companies, providing research and development, clinical trial, regulatory and other services. Signet is based in Dedham, Mass., and provides antibodies used in the research of cancer, infectious and other diseases.
Covance in $8.9M Signet Acquisition
Martin C. Daks
NJBIZ Staff
6/1/2006
Covance has announced that is has acquired substantially all of the assets belonging to Signet Laboratories for $8.9 million. Princeton-based Covance is a drug development services firm. It works with pharmaceutical and biotech companies, providing research and development, clinical trial, regulatory and other services. Signet is based in Dedham, Mass., and provides antibodies used in the research of cancer, infectious and other diseases.
posted by Jones Lang LaSalle NJ News Blog at 4:22 PM
<< Home